Pharmacokinetics, safety, and tolerability of sodium phenylacetate and sodium benzoate in healthy Japanese volunteers: A phase I, single-center, open-label study
Open Access
- 8 September 2022
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 48, 100474
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Long‐term outcome of urea cycle disorders: Report from a nationwide study in JapanJournal of Inherited Metabolic Disease, 2021
- Urea cycle disorders—updateJournal of Human Genetics, 2019
- Suggested guidelines for the diagnosis and management of urea cycle disorders: First revisionJournal of Inherited Metabolic Disease, 2019
- Characterisation of the influence of genetic variations on the enzyme activity of a recombinant human glycine N-acyltransferaseGene, 2013
- Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N-acyltransferase in human hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2012
- Long‐term outcome and intervention of urea cycle disorders in JapanJournal of Inherited Metabolic Disease, 2011
- Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle DisordersNew England Journal of Medicine, 2007
- Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteersMolecular Genetics and Metabolism, 2004
- Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acidsBiochimica et Biophysica Acta (BBA) - General Subjects, 1999